Correction to: Signal Transduction and Targeted Therapy (2024) 9:327; https://doi.org/10.1038/s41392-024-02058-x; Article published online 20 November 2024
After the online publication of the research highlight,1 a reader pointed out that the MVA vaccine used in the original study by Mucker et al.2 was mistakenly labeled as “Jynneos”. The authors have now pointed out in the text, that the comparator vaccine used in the original study was the MVA-572 strain and not the MVA-BN (Jynneos) vaccine. The explanations “vaccine study” and “mpox virus challenge” were added to the first panel of Fig. 1 to clarify the study design. In the lower panel, the antibody functions were provided in more detail to avoid misunderstanding by the readers. The corrected figure is provided below. The main messages of this research highlight are not affected by these corrections.
Incorrect Figure
Correct Figure
The original article has been corrected.
References
Mayer, L., Weskamm, L. M. & Addo, M. M. Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. Signal Transduct. Target. Ther. 9, 1–3 (2024).
Mucker, E. M. et al. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187, 5540–5553.e10 (2024).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mayer, L., Weskamm, L.M. & Addo, M.M. Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. Sig Transduct Target Ther 9, 363 (2024). https://doi.org/10.1038/s41392-024-02092-9
Published:
Version of record:
DOI: https://doi.org/10.1038/s41392-024-02092-9
